Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2550190 | 0.71 | SMPD2 (0.41) | ALDH1A1TSHRMEN1KMT2ADPP4 | |
| SCHEMBL2733646 | 0.70 | TSHR (0.30) | TSHR | |
| SCHEMBL787268 | 0.69 | MEN1 (0.32) | ALDH1A1MEN1KMT2A | |
| SCHEMBL15284768 | 0.67 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL7115253 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL7975590 | 0.67 | MEN1 (0.31) | ALDH1A1MEN1KMT2A | |
| SCHEMBL12923162 | 0.67 | — | — | |
| Bromide SCHEMBL11042423 | 0.67 | MEN1 (0.31) | ALDH1A1MEN1KMT2A | |
| SCHEMBL10615339 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL89279 | 0.67 | KMT2A (0.33) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7605107-B2 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-10-20 | — | — | US | claimed |
| US-7538066-B2 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-05-26 | — | — | US | claimed |
| US-20070082811-A1 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-04-12 | — | — | US | claimed |
| US-20070072765-A1 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-03-29 | — | — | US | claimed |
| US-9035107-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-19 | — | — | US | disclosed |
| US-9024078-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-8969639-B2 | Dehydrogenation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-03-03 | — | — | US | disclosed |
| US-8884075-B2 | Process for producing phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-20140148620-A1 | Process for Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-05-29 | — | — | US | disclosed |
| US-20120323046-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-12-20 | — | — | US | disclosed |
| EP-2531480-A1 | DEHYDROGENATION PROCESS | ExxonMobil Chemical Patents Inc. (US) | 2012-12-12 | — | — | EP | disclosed |
| US-20120302798-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-11-29 | — | — | US | disclosed |
| US-20120271077-A1 | Dehydrogenation Process | EXXONMOBILE CHEMICAL PATENTS INC. (US) | 2012-10-25 | — | — | US | disclosed |
| WO-2012050665-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2011096992-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096997-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096994-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148620-A1 | Process for Producing Phenol | HPD, CYP2J2, CYP2E1 | ALDH1A1 1756/4885TSHR 4291/4885MEN1 3600/4885 |
| US-20120271077-A1 | Dehydrogenation Process | ADH5, ADH1A, ADH1C | ALDH1A1 40/4885TSHR 4452/4885MEN1 3747/4885 |
| US-20120302798-A1 | Dehydrogenation Process | NDUFV1, NDUFV2, MAFG | ALDH1A1 274/4885TSHR 4824/4885MEN1 1335/4885 |
| US-20120323046-A1 | Dehydrogenation Process | ADH1A, ADH5, ADH1C | ALDH1A1 85/4885TSHR 3816/4885MEN1 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.